They hit record backlog and raised guidance, then bought Carlyle's stake in Rigaku with cash and couldn't explain the return on a per-tool basis.
Thesis: Every additional packaging process step at sub-6-micron bump heights is another inspection or metrology tool Onto sells. Advanced packaging growing 50%+ in 2026 against a WFE market growing low-20s is a structural share shift backed by real competitive wins: G5 head-to-head at 2.5D logic, TSV metrology displacement, JetStep qualified at two packaging suppliers. The bear's concern about 2027 backlog promises and Rigaku capital allocation is valid but doesn't break the current-year numbers.
Verdict: LONG — Conviction: MEDIUM
Catalyst: Dragonfly G5 ramping through Q3 and Q4 with shipments accelerating each quarter. Rigaku close in H2 2026 adding licensing revenue. JetStep 2027 ramp at two packaging suppliers. Each is near-term, not a 2030 story.
Key Risk: H2 must accelerate 15% over H1 to clear $1.3B while absorbing rising memory and freight costs. Miss one quarter of the G5 ramp and the full-year guide breaks. Lead times extending and supply chain bottlenecks acknowledged but waved away.
The Tell: Analyst asked for per-tool Rigaku licensing economics. Plisinski said 'we're not going to break that down for anybody' then gave residual math: foregone interest income minus $7M dividends equals licensing plus hybrid metrology profit. On a $710M outlay, that residual implies single-digit millions. He revealed the return is thin while trying to frame it as adequate.
Friction Level: MODERATE_FRICTION — Both sides agree the operational quarter is clean. Disagreement centers on whether the 30% growth guide with continuous margin expansion is achievable given acknowledged supply chain bottlenecks, and whether Rigaku's $710M deployment destroys or creates value.
Report not found
The report data is no longer available. Please return to the archive.